Clinical Trial Update: Anamorelin Study for Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of anamorelin in metastatic pancreatic cancer was terminated, with results posted on 2025-11-17.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Anamorelin (anamorelin)

Snippet

Sponsor: Lahey Clinic | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-11-17